Showing results (31-40 of 45) with videos related to

Sort By:
Pageof 5
Cancer Research|June 25, 2009
Lymphopenia as a prognostic factor for overall survival in advanced carcinomas, sarcomas, and lymphomasIsabelle Ray-Coquard, Claire Cropet, Martine Van Glabbeke, et al.
The Lancet. Oncology|March 25, 2018
Nilotinib in locally advanced pigmented villonodular synovitis: a multicentre, open-label, single-arm, phase 2 trialHans Gelderblom, Claire Cropet, Christine Chevreau, et al.
International Journal of Clinical Oncology|August 13, 2013
Territorial inequalities in management and conformity to clinical guidelines for sarcoma patients: an exhaustive population-based cohort analysis in the Rhône-Alpes regionPierre Etienne Heudel, Philippe Cousin, Antoine Lurkin, et al.
European Journal of Cancer (Oxford, England : 1990)|January 12, 2023
Efficacy and safety of maintenance olaparib and bevacizumab in ovarian cancer patients aged ≥65 years from the PAOLA-1/ENGOT-ov25 trialRenaud Sabatier, Frédérique Rousseau, Florence Joly, et al.
British Journal of Cancer|September 24, 2025
Vaginal germ cell tumors: results from the international retrospective VAGIPED studyCécile Faure-Conter, Luiz Fernando Lopes, Yijin Gao, et al.
The Oncologist|December 14, 2024
Safety and quality of life with maintenance olaparib plus bevacizumab in older patients with ovarian cancer: subgroup analysis of PAOLA‑1/ENGOT-ov25Coline Montégut, Claire Falandry, Saverio Cinieri, et al.
BMC Cancer|November 26, 2014
The off-label use of targeted therapies in sarcomas: the OUTC'S programLauriane Eberst, Claire Cropet, Axel Le Cesne, et al.
Cancers|November 11, 2022
Structural and Socio-Spatial Determinants Influencing Care and Survival of Patients with a Pancreatic Adenocarcinoma: Results of the PANDAURA CohortGaël S Roth, Yohan Fayet, Sakina Benmameche-Medjahed, et al.
Gynecologic Oncology|December 25, 2021
Efficacy of maintenance olaparib plus bevacizumab according to clinical risk in patients with newly diagnosed, advanced ovarian cancer in the phase III PAOLA-1/ENGOT-ov25 trialPhilipp Harter, Marie Ange Mouret-Reynier, Sandro Pignata, et al.
BMC Cancer|June 10, 2018
A first-in-human study investigating biodistribution, safety and recommended dose of a new radiolabeled MAb targeting FZD10 in metastatic synovial sarcoma patientsAnne-Laure Giraudet, Philippe Alexandre Cassier, Chicaco Iwao-Fukukawa, et al.
Pageof 5